Glucose Monitoring Devices Market to Reach USD 67.74 Billion by 2033 | 17% CAGR | North America Leads with 35% Share | Key Players: Abbott, Medtronic, Dexcom, Roche, Senseonics, LifeScan

Glucose Monitoring Devices Market:

The global glucose monitoring devices market reached US$ 16.65 billion in 2024 and is projected to expand to US$ 67.74 billion by 2033, growing at a CAGR of 17.0% during the forecast period 2025-2033. The market is experiencing robust growth, driven by demographic shifts, technological innovations, and evolving healthcare needs. The rising prevalence of diabetes, fueled by aging populations, sedentary lifestyles, and unhealthy dietary habits, is creating strong demand for efficient and reliable blood glucose monitoring solutions. Continuous Glucose Monitoring (CGM) systems and Self-Monitoring of Blood Glucose (SMBG) devices have become critical tools in diabetes management, enabling patients and healthcare providers to track blood sugar levels in real-time and make informed decisions regarding treatment. Technological advancements-including non-invasive wearable sensors, smartphone connectivity, cloud-based data sharing, and AI-powered analytics-are enhancing the accuracy, functionality, and convenience of these devices, improving patient compliance and outcomes.

Additionally, government initiatives and healthcare reforms are accelerating market adoption. Reimbursement policies in developed countries, along with public-private partnerships and health programs in emerging economies, are facilitating access to advanced glucose monitoring solutions. These combined factors position the glucose monitoring devices market for significant growth over the next decade, as healthcare systems increasingly prioritize proactive diabetes management and digital health integration.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/glucose-monitoring-devices-market?Juli

Recent Developments:

✅ August 2025: Abbott launched the FreeStyle Libre 2 Plus, a next-generation continuous glucose monitoring (CGM) system providing real-time glucose readings every minute with optional customizable alarms, enhancing diabetes management without routine fingersticks.

✅ May 2025: Abbott's FreeStyle Libre technology was linked with reduced cardiovascular-related hospitalizations among people with diabetes, highlighting expanded clinical benefits of CGM adoption.

✅ April 2025: Medtronic submitted FDA applications for its MiniMed 780G insulin pump integrated with SmartGuard algorithm, enabling automated insulin delivery using CGM data for improved glycemic control.

✅ June 2025: A startup in India launched a Bluetooth-enabled CGM device that syncs with a mobile app for real-time alerts, providing a cost-effective solution for diabetes management.

✅ Q1-Q2 2025: Companies including Dexcom, Medtronic, and Roche expanded their advanced CGM product lines featuring shorter warm-up times, longer wear durations, predictive alarms, and enhanced smartphone integration.

Mergers & Acquisitions:

✅ July 2025: Abbott acquired a data analytics startup specializing in AI-driven glucose trend prediction to enhance predictive capabilities in its CGM systems.

✅ May 2025: Medtronic partnered with a digital health platform to integrate CGM data with telemedicine services, enabling remote diabetes management for patients.

✅ March 2025: Dexcom acquired a sensor technology firm to develop next-generation non-invasive glucose monitoring solutions, aiming to expand its wearable CGM portfolio.

Buy Now & Unlock 360° Market Intelligence:-https://www.datamintelligence.com/buy-now-page?report=glucose-monitoring-devices-market?Juli

Key Players
• Abbott - Holds a 28% share, driven by its FreeStyle Libre CGM systems, continuous innovation in non-invasive glucose monitoring, and strong global distribution network.

• Medtronic - Holds a 22% share, supported by its MiniMed insulin pumps integrated with SmartGuard CGM technology, offering automated insulin delivery and advanced diabetes management solutions.

• Roche - Holds a 15% share, fueled by Accu-Chek CGM and SMBG devices, coupled with software solutions for diabetes data tracking and cloud-based analytics.

• Dexcom - Holds a 20% share, led by its G6 and G7 CGM systems with real-time alerts, smartphone integration, and AI-powered predictive algorithms for glycemic control.

• Senseonics - Holds a 7% share, backed by its Eversense implantable CGM system with long-term wearability and mobile app-based monitoring.

• LifeScan - Holds an 8% share, driven by its OneTouch blood glucose monitoring devices and integration with digital health platforms for diabetes management.

Market Segmentation:

➥ By Product Type: Continuous Glucose Monitoring (CGM) systems hold a 60% share of the market due to real-time monitoring capabilities, AI-driven analytics, and growing adoption among Type 1 and Type 2 diabetes patients. Self-Monitoring of Blood Glucose (SMBG) devices account for 35%, favored for affordability and periodic glucose checks. Emerging non-invasive wearable sensors represent 5%, with rapid growth potential.

➥ By Indication: Type 2 diabetes dominates with a 70% share owing to its higher global prevalence. Type 1 diabetes represents 25%, driven by younger populations and the need for continuous monitoring. Gestational diabetes and other indications make up the remaining 5%, increasing due to prenatal awareness initiatives.

➥ By End User: Hospitals and clinics account for 50% of the market, being the primary adopters for patient monitoring and institutional programs. Home care and self-monitoring represent 40%, fueled by rising adoption of CGM and SMBG devices. Diagnostic centers, telehealth platforms, and other users make up 10% of the market.

Regional Insights:

North America dominates the global glucose monitoring devices market with a 35% share, driven by high prevalence of diabetes, advanced healthcare infrastructure, widespread adoption of Continuous Glucose Monitoring (CGM) systems, and strong reimbursement policies. The U.S. leads the region due to early adoption of innovative devices, integration of AI-driven analytics, and robust healthcare awareness programs.

Europe holds a 25% share, supported by government initiatives for diabetes management, growing awareness of continuous glucose monitoring, and strong healthcare infrastructure in countries such as Germany, the UK, and France. Rising demand for homecare monitoring and SMBG devices also contributes to regional growth.

Asia-Pacific is the fastest-growing market with a 30% share and a projected high CAGR. Increasing diabetes prevalence, growing healthcare awareness, expanding healthcare infrastructure, and rising disposable income in countries such as India, China, and Japan are fueling adoption. Government programs promoting early diagnosis and disease management further boost the market.

Latin America, the Middle East & Africa (LAMEA) collectively account for 10% of the market. Growth in these regions is driven by increasing diabetes awareness, healthcare investments, and rising adoption of glucose monitoring devices, though slower infrastructure development and limited access to advanced devices restrict overall market share.

Speak to Our Analyst and Get Customization in the report as per your requirements:-https://www.datamintelligence.com/customize/glucose-monitoring-devices-market?Juli

Market Dynamics:

Driver:
The global glucose monitoring devices market is primarily driven by the increasing prevalence of diabetes worldwide. Both type 1 and type 2 diabetes are on the rise, fueled by aging populations, sedentary lifestyles, and unhealthy diets, which significantly increase the need for effective diabetes management tools. Regular glucose monitoring is crucial for maintaining blood sugar levels and preventing long-term complications, driving demand for self-monitoring blood glucose (SMBG) devices and continuous glucose monitoring (CGM) systems. This rising health concern is accelerating innovation, expanding user bases, and encouraging adoption across both developed and developing regions.

According to the International Diabetes Federation, 11.1% of adults (20-79 years) currently live with diabetes, with over 40% unaware of their condition. By 2050, approximately 1 in 8 adults around 853 million people are projected to be affected, a 46% increase. Over 90% of diabetes patients have type 2 diabetes, driven by socio-economic, demographic, environmental, and genetic factors, including urbanization, aging populations, reduced physical activity, and rising obesity rates.

Restraint: High cost of advanced monitoring devices
The market faces challenges due to the high cost of advanced glucose monitoring technologies, particularly CGM systems. Affordability issues, especially in low- and middle-income countries, hinder widespread adoption. Limited insurance coverage and reimbursement policies further restrict access. Additionally, the high upfront costs and recurring expenses for sensors and accessories slow market penetration in cost-sensitive regions, constraining overall growth.

📌 Request for 2 Days FREE Trial Access: https://www.datamintelligence.com/reports-subscription

☛ Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape

✅ Sustainability Impact Analysis

✅ KOL / Stakeholder Insights

✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots

✅ Market Volatility & Emerging Risks Analysis

✅ Quarterly Industry Report Updated

✅ Live Market & Pricing Trends

✅ Import-Export Data Monitoring

☛ Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg?Juli

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.